Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Clostridioides difficile

Tag: Clostridioides difficile

  • BiotechToday
  • World

Novel Strategies for Clostridioides Difficile Infection Treatment

BioTech Today July 15, 2021July 14, 2021 2

Subhajit Nan, Amity University, Kolkata Clostridioides Difficile is a bacterium responsible for causing severe diarrhea and inflammation of the colon (colitis). Though guidelines for infection control measures are firmly in place, Clostridioides Difficile Infection or CDI remains the chief cause of diarrhea associated with healthcare. Since the burden associated with CDI is high, both from […]

Read More
  • BiotechToday
  • World

A new therapeutic avenue in Clostridioides difficile Infection

bioxone June 22, 2021June 21, 2021

Akshita Kumar Clostridioides difficile is an anaerobic Gram-positive bacteria that is capable of forming spores. Clostridioides difficile infection (CDI) is the most common reason behind hospital-acquired gastrointestinal infections and mortality in industrialised nations, with an estimated 223,900 infections, 12,800 deaths, and a $1 billion healthcare cost in 2017. In recent years, there has also been a rise in the number of community-associated […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy